ChronoScale (CHRN) vs Imax (IMAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ChronoScale (CHRN) has outperformed Imax (IMAX) over the past year, gaining 266.1% versus a gain of 57.0%. Over five years, IMAX leads with a +151.8% price change compared with -68.0% for CHRN. ChronoScale is the larger company by market cap ($2.88 billion vs $2.82 billion), about 1.0 times the size.
Imax converts more of its revenue into profit, with a net margin of 8.5% versus -70.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CHRN | IMAX |
|---|---|---|
| Share price | $19.77 | $51.45 |
| Market cap | $2.88B | $2.82B |
| 1-day change | +2.54% | +1.72% |
| YTD return | +128.82% | +39.20% |
| 1-year return | +266.11% | +57.00% |
| 5-year return | -68.01% | +151.84% |
| P/E ratio (TTM) | — | 70.48 |
| Forward P/E | — | 24.44 |
| EPS (TTM) | $-0.36 | $0.73 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $71.60M | $410.21M |
| Revenue growth (YoY) | +459.45% | +16.47% |
| Net income (latest FY) | $-50.32M | $34.88M |
| Gross margin | -23.86% | 60.02% |
| Operating margin | -52.37% | 20.53% |
| Net margin | -70.28% | 8.50% |
| 52-week high | $30.00 | $57.73 |
| 52-week low | $3.50 | $30.74 |
| Distance from 52-week high | -34.10% | -10.88% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +61.86% | +9.48% |
| Average volume | 189.34K | 1.25M |
| Shares outstanding | 145.64M | 54.84M |
| Employees | 84 | 679 |
| Sector | Industrials | Consumer Discretionary |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CHRN has outperformed IMAX by 209.1 percentage points over the past year.
- Imax is more profitable, keeping 8.5 cents of every revenue dollar as net income versus -70.3 cents for ChronoScale.
- ChronoScale grew revenue faster in its latest fiscal year (+459.45% vs +16.47%).
- The two companies sit in different sectors: ChronoScale in Industrials and Imax in Consumer Discretionary.
About ChronoScale
CHRN stock →ChronoScale Holdings Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads in the United States. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution.
Industrials · Industrial Machinery/Components · 84 employees
About Imax
IMAX stock →IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events in the United States, Canada, Greater China, rest of Asia, Western Europe, Latin America, and internationally. It operates through Content Solutions; and Technology Products and Services segments.
Consumer Discretionary · Industrial Machinery/Components · 679 employees
CHRN vs IMAX FAQ
Which is bigger, ChronoScale or Imax?
ChronoScale (CHRN) is larger, with a market capitalization of $2.88B compared with $2.82B for Imax (IMAX).
Which stock has performed better over the past year, CHRN or IMAX?
CHRN returned +266.11% over the past 12 months, compared with +57.00% for IMAX (price return, excluding dividends). Past performance does not predict future results.
Are ChronoScale and Imax in the same industry?
Yes. Both are classified in the Industrial Machinery/Components industry within the Industrials sector.